Cellectar announces the election of dr. asher alban chanan-khan to its board of directors

Florham park, n.j., june 24, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that dr. asher alban chanan-khan has been elected to its board of directors as an independent director.

CLRB Ratings Summary

CLRB Quant Ranking